Systemic Amyloidosis clinical trials

Explore recruiting systemic amyloidosis clinical trials.

Recruiting systemic amyloidosis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Systemic Amyloidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective, monocentric, exploratory phase II study for the evaluation of the diagnostic use of the tracer PET (18F) -Flutemetamol (Vizamyl®) in patients with cardiac amyloidosis

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Systemic Amyloidosis trials by city

Systemic Amyloidosis clinical trials

Recruiting systemic amyloidosis studies right now

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Optimize First-line Treatment for AL Amyloidosis With t (11; 14)

Daratumumab for Patients With Light Chain Amyloidosis

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis

Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients

Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis

Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis

Also recruiting in Europe

Prospective, monocentric, exploratory phase II study for the evaluation of the diagnostic use of the tracer PET (18F) -Flutemetamol (Vizamyl®) in patients with cardiac amyloidosis

Systemic Amyloidosis trials by city

Other conditions